Bayesian Capital Management’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Bayesian Capital Management's ORCL Position: Q2 2026 in Review
Bayesian Capital Management increased its Oracle (ORCL) stake by 1,024% in Q2 2026, buying an estimated $5.76M and bringing the position to 34,855 shares worth $5.11M. The position accounts for 3.27% of the portfolio, ranked #4.
Bayesian Capital Management first reported a position in ORCL in Q1 2016 and has held it in 17 quarters since. The position peaked at $17.1M in Q1 2024. 3,527 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Bayesian Capital Management held 34,855 shares of Oracle worth $5.11M as of Q2 2026.
- Bayesian Capital Management bought 31,755 Oracle shares in Q2 2026, an estimated $5.76M.
- Oracle made up 3.27% of Bayesian Capital Management's portfolio in Q2 2026, its #4 holding.
- Bayesian Capital Management first reported a position in Oracle in Q1 2016 and has held it in 17 quarters since.
- Bayesian Capital Management's Oracle position peaked at $17.1M in Q1 2024.
- 3,527 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.